Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 67 clinical trials
Featured trial
Eltrombopag for People With Fanconi Anemia

Fanconi anemia is a genetic disease. Some people with it have reduced blood cell counts. This means their bone marrow no longer works properly. These people may need blood transfusions for anemia

anemia studies
anemia
fanconi's syndrome
fanconi's anemia
  • 143 views
  • 22 Dec, 2020
  • 1 location
Featured trial
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

attacking the bone marrow. However, this treatment does not work in all people. Some people still have poor blood cell counts even after treatment. Eltrombopag is a drug designed to mimic a protein

anemia studies
myelodysplastic syndromes
myelodysplastic syndrome (mds)
anemia
aplastic anemia
  • 172 views
  • 22 Dec, 2020
  • 1 location
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

: Phlebotomy therapy every 1 to 2 weeks, depending on iron levels Blood sample collection for blood cell counts and iron studies at every phlebotomy session Blood

Accepts healthy volunteers
  • 114 views
  • 25 Oct, 2022
  • 1 location
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

-operative central endothelial cell counts. The anticipated enrollment is 25 patients.

  • 0 views
  • 07 Oct, 2022
  • 1 location
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study

The RECOVER study is a self-controlled case series to evaluate whether the addition of Fostemsavir (Rukobia) to a stable HIV regimen in virologically suppressed patients living with HIV who never experience optimal CD4 T-cell count recovery can result in meaningful increases in different immunologic parameters such as CD4 T-cell count, …

  • 0 views
  • 11 Oct, 2022
  • 1 location
Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection

Gut bacterial community diversity and composition, immune recovery and activation in peripheral plasma/mucosa, plasma levels of gut damage, microbial translocation and inflammation at baseline and after 6 months of receiving intervention will be analyzed.

  • 0 views
  • 25 Apr, 2022
  • 1 location
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Objectives Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

  • 0 views
  • 15 Jun, 2022
  • 1 location
A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

The purpose of this study is to evaluate the effects of KER-050 on anemia in patients with very low, low or intermediate risk MDS.

anemia
bone marrow procedure
blood transfusion
  • 72 views
  • 28 Oct, 2022
  • 18 locations
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals

Early diagnosis can contribute to good treatment outcomes and isolate infection control.

  • 4 views
  • 11 Apr, 2022
  • 4 locations
Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

The purpose of this research study is to test the safety and efficacy of a drug called Plerixafor. Plerixafor is approved by the US FDA for use in increasing blood stem cell counts before

gene therapy
absolute neutrophil count
thalassemia
cancer
plerixafor
  • 34 views
  • 18 Apr, 2022
  • 1 location